Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Dental Products Advisory Panel

This article was originally published in The Gray Sheet

Executive Summary

Scheduled to meet Dec. 5-7 at the Renaissance Hotel in Washington, D.C. The first day of the meeting will cover dental device ingredient labeling and a draft guidance on temporomandibular joint implants. On Dec. 6, the panel's plaque subcommittee is slated to discuss OTC anti-plaque products, while the Dec. 7 agenda calls for discussion of guidance documents for endosseous implants and dental handpieces. For information, call Jeanne Rippere or Stephanie Mason at 301/594-1003
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT003095

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel